Found 11 matching trials
A Dose Ranging Trial of 4 Doses of Indacaterol Delivered Via the TWISTHALER® Device in Patients With Chronic Obstructive Pulmonary Disease (COPD) PHASE2 This study will evaluate the dose response relationship among four doses of...
Show More Location
Novartis Investigator site
Learn More & Join Trial
A Drug Utilisation Post-authorisation Study of New Users of Aclidinium Bromide (Monotherapy or in Combination) N/A DUS1 and DUS2 are descriptive drug utilisation studies in new users of acli...
Show More Location
National Health Database Denmark, Southern Denmark University
Learn More & Join Trial
A Study to Compare Fluticasone /Formoterol Breath Actuated Inhaler (BAI) and Ultibro in Subjects With Fixed Airflow Obstruction and Elevated Eosinophils PHASE2 The purpose of this study is to investigate whether fluticasone/formoterol ...
Show More Learn More & Join Trial
A 1-year Multi-center, Prospective, Cohort Study in Patients With Chronic Obstructive Pulmonary Disease Treated With Long-acting Bronchodilator PHASE4 This multi-center study is designed to describe natural history of disease,...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Efficacy of Indacaterol 150 µg Versus Formoterol PHASE4 The study will be a 12 week treatment (84 days), parallel group, randomized...
Show More Location
Multiple Locations
Learn More & Join Trial
ANTES B+ Clinical Trial PHASE4 Current guidelines recommend initial treatment with dual long-acting bronch...
Show More Location
Hospital Clínic Barcelona
Learn More & Join Trial
Efficacy, Safety, and Tolerability of Once Daily Indacaterol in Chronic Obstructive Pulmonary Disease (COPD) Using Formoterol Twice Daily as Active Control PHASE3 This study was designed to assess the efficacy and long-term safety of 300 ...
Show More Location
Novartis Investigator Site
Learn More & Join Trial
Acute Effect of Pulmonary Desufflation on Cardiac Performance in COPD Patients PHASE4 Chronic Obstructive Pulmonary disease (COPD) is one of the major clinical e...
Show More Location
Pneumologia Riabilitativa-Fondazione Maugeri-Istituto Scientifico di Milano- IRCCS
Learn More & Join Trial
26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) PHASE2 Stage 1 of the study is designed to provide data about the risk-benefit of ...
Show More Location
Pinnacle Research Group, LLC
Learn More & Join Trial
The Effect of QVA149 on Health Related Quality of Life in Patients With Chronic Obstructive Pulmonary Disease (COPD) PHASE3 This study will assess the efficacy and safety of QVA149 compared to tiotro...
Show More Location
Novartis Investigative Site
Learn More & Join Trial